check_circleStudy Completed

Diagnostic imaging

Bayer Identifier:

Trial_86238

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

6 - 12 Years
  • -

  • -

Trial summary

Enrollment Goal
26
Trial Dates
January 1987 - October 1988
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children (6 to 12 years)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.